Physician profile
Stephen Frank Schiff
NPI 1598723124
$12,880.00
in general payments reported to CMS, 2019-2025
18 companies · $698 in 2025
The $698 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,103 · 2020: $4,034 · 2021: $138 · 2022: $102 · 2023: $436 · 2024: $369 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489 · Education: $13.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.19 |
| Education | $13.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $11,059.81 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $340.98 | 2019-2025 | Speedicath |
| Sumitomo Pharma America, INC. | $279.56 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $182.15 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $179.17 | 2022-2024 | Urolift |
| Telix Pharmaceuticals | $149.95 | 2023-2025 | Illuccix |
| Ferring Pharmaceuticals INC. | $137.59 | 2019-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $133.31 | 2024-2025 | |
| Immunitybio, INC. | $82.87 | 2025 | |
| Progenics Pharmaceuticals, INC. | $75.71 | 2023-2024 | Pylarify |
| Antares Pharma, INC. | $66.33 | 2022-2025 | Xyosted |
| Urovant Sciences INC | $43.95 | 2022 | |
| Urogen Pharma, INC. | $43.82 | 2025 | |
| Kci USA, INC. | $25.55 | 2020 | |
| Olympus America INC. | $25.31 | 2023 | Itind System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.55 | 2025 | |
| Innovation Technologies INC | $17.33 | 2025 | Irrisept |
| Amgen INC. | $14.06 | 2023 | Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.